US Physical Therapy/$USPH
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About US Physical Therapy
US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
Ticker
$USPH
Sector
Primary listing
NYSE
Industry
Health Care Providers and Services
Headquarters
Employees
5,531
ISIN
US90337L1089
Website
USPH Metrics
BasicAdvanced
$1.1B
34.47
$2.17
1.44
$1.78
2.40%
Price and volume
Market cap
$1.1B
Beta
1.44
52-week high
$99.60
52-week low
$62.77
Average daily volume
233K
Dividend rate
$1.78
Financial strength
Current ratio
1.174
Quick ratio
1.063
Long term debt to equity
33.982
Total debt to equity
40.488
Dividend payout ratio (TTM)
79.75%
Interest coverage (TTM)
8.48%
Profitability
EBITDA (TTM)
91.058
Gross margin (TTM)
21.75%
Net profit margin (TTM)
4.81%
Operating margin (TTM)
10.20%
Effective tax rate (TTM)
24.42%
Revenue per employee (TTM)
$130,000
Management effectiveness
Return on assets (TTM)
4.02%
Return on equity (TTM)
6.63%
Valuation
Price to earnings (TTM)
34.474
Price to revenue (TTM)
1.634
Price to book
2.29
Price to tangible book (TTM)
-3.21
Price to free cash flow (TTM)
20.229
Free cash flow yield (TTM)
4.94%
Free cash flow per share (TTM)
370.50%
Dividend yield (TTM)
2.37%
Forward dividend yield
2.40%
Growth
Revenue change (TTM)
14.31%
Earnings per share change (TTM)
81.25%
3-year revenue growth (CAGR)
10.80%
10-year revenue growth (CAGR)
8.42%
3-year earnings per share growth (CAGR)
-8.83%
10-year earnings per share growth (CAGR)
3.07%
3-year dividend per share growth (CAGR)
5.21%
10-year dividend per share growth (CAGR)
13.25%
What the Analysts think about USPH
Analyst ratings (Buy, Hold, Sell) for US Physical Therapy stock.
Bulls say / Bears say
Analysts have set a bullish average target price of $106.00, representing a compelling 37.06% potential upside from current levels. This optimism is further underscored by the analyst ratings, which include six buy recommendations and only one hold, with no sell ratings. (directorstalkinterviews.com)
USPH's financial performance showcases a healthy 18.10% revenue growth, driven by its expansive service offerings, including pre-and post-operative care, injury rehabilitation, and ergonomic assessments. (directorstalkinterviews.com)
USPH’s free cash flow of over $54 million underscores its ability to reinvest in growth opportunities and maintain financial flexibility. (directorstalkinterviews.com)
Operating cash flow turned negative in Q1 2025, using $4.7 million compared to providing $4.4 million in Q1 2024, primarily due to working capital changes, including a decrease in accrued expenses from $68.3 million to $59.5 million and an increase in patient accounts receivable from $59.0 million to $64.8 million. (panabee.com)
Gross margin fell to 18.5% due to rising salaries per visit (up 4.2%) and increased operating costs per visit (up 4.4%), outpacing revenue growth. (panabee.com)
Clinic closures tripled to 45 in FY 2024, compared to 15 in the previous year, signaling potential operational or integration issues. (panabee.com)
Data summarised monthly by Lightyear AI. Last updated on 12 Jul 2025.
USPH Financial Performance
Revenues and expenses
USPH Earnings Performance
Company profitability
USPH News
AllArticlesVideos
U.S. Physical Therapy Presented at Investor Conferences
Business Wire·1 month ago
U.S. Physical Therapy Announces Dual Listing on NYSE Texas
Business Wire·2 months ago
U.S. Physical Therapy Clinics Market Analysis 2025: $53 Billion Industry Primed for Consolidation - M&A Activity Surges in Fragmented Therapy Sector
GlobeNewsWire·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for US Physical Therapy stock?
US Physical Therapy (USPH) has a market cap of $1.1B as of July 18, 2025.
What is the P/E ratio for US Physical Therapy stock?
The price to earnings (P/E) ratio for US Physical Therapy (USPH) stock is 34.47 as of July 18, 2025.
Does US Physical Therapy stock pay dividends?
Yes, the US Physical Therapy (USPH) stock pays dividends to shareholders. As of July 18, 2025, the dividend rate is $1.78 and the yield is 2.4%. US Physical Therapy has a payout ratio of 79.75% on a trailing twelve-month basis.
When is the next US Physical Therapy dividend payment date?
The next US Physical Therapy (USPH) dividend payment date is unconfirmed.
What is the beta indicator for US Physical Therapy?
US Physical Therapy (USPH) has a beta rating of 1.44. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.